ASX Announcement

CLINUVEL secures IP for melanocortins to treat CNS disorders

Published: 14/07/23, 09:23am (AEST)4 pages
Clinuvel Pharmaceuticals Limited
CUV:ASXHealthcare

Recent CUV Announcements

Price Sensitive only